Indo Borax & Chemicals Ltd
Indo Borax & Chemicals Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
The short version
Indo Borax expects revenue of Rs. The company aims for long-term value creation rather than just quarter-to-quarter focus. - For FY 27-28, an EBITDA margin of around 20% is expected, slightly lower than the exceptional Q1 EBITDA of 28%. - Revenue guidance for the current year is Rs.
From Indo Borax & Chemicals Ltd's Q1 FY27 earnings-call transcript · updated 9 Sept 2026.
Revenue & Sales Performance
- Indo Borax expects revenue of Rs. 250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms.
- Plans to add capacities in Boron oxide and Boric acid to drive further margin expansion and year-on-year growth.
- Kronox's revenue potential is expected to be 3 to 3.5 times current levels after completion of Dahej capex.
- Dahej capex benefits to start reflecting from FY29, with full impact by FY30-31.
- Kronox's existing plants are at full utilization but operational improvements could provide 15-20% additional capacity before capex benefits.
2 more points from Indo Borax & Chemicals Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Indo Borax & Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Indo Borax plans approximately Rs. 50 crores capex over the next 2-3 years, primarily in Boron Oxide (Rs. 20 crores) and Boric Acid (Rs. 20-25 crores), with some allowance for inflation rounding to Rs. 50 crores.
- There is also planned capex for Zinc Borate as part of the overall Rs. 50 crores investment in specialty chemical expansion.
- Kronox has a capex plan of about Rs. 110 crores to be executed in phases, with Rs. 80 crores already in cash on their balance sheet. The initial phase will use Rs. 55-60 crores, fully funded from internal accruals.
- The Kronox capex execution is expected to take 18-24 months.
2 more points from Indo Borax & Chemicals Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Indo Borax & Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Indo Borax & Chemicals Ltd — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹63 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Indo Borax & Ch.'s management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride Ltd (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst Ltd (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Indo Borax & Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Indo Borax & Chemicals Ltd Q1 FY27 results?
Indo Borax expects revenue of Rs. The company aims for long-term value creation rather than just quarter-to-quarter focus. - For FY 27-28, an EBITDA margin of around 20% is expected, slightly lower than the exceptional Q1 EBITDA of 28%. - Revenue guidance for the current year is Rs.
What is Indo Borax & Chemicals Ltd share price analysis?
Indo Borax & Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 33.8 with a market cap of ₹1,652 Cr. Investors should review the full earnings analysis for detailed insights.
Is Indo Borax & Chemicals Ltd planning capital expenditure?
Indo Borax plans approximately Rs.
Keep Indo Borax & Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.